Abstract

Mortality in neonates with Gram-negative bloodstream infections has remained unacceptably high. Very few data are available on the impact of resistance profiles, virulence factors, appropriateness of empirical treatment and clinical characteristics on patients’ mortality. A survival analysis to investigate 28-day mortality probability and predictors was performed including (I) infants <90 days (II) with an available Enterobacterales blood isolate with (III) clinical, treatment and 28-day outcome data. Eighty-seven patients were included. Overall, 299 virulence genes were identified among all the pathogens. Escherichia coli had significantly more virulence genes identified compared with other species. A strong positive correlation between the number of resistance and virulence genes carried by each isolate was found. The cumulative probability of death obtained by the Kaplan-Meier survival analysis was 19.5%. In the descriptive analysis, early age at onset, gestational age at onset, culture positive for E. coli and number of classes of virulence genes carried by each isolate were significantly associated with mortality. By Cox multivariate regression, none of the investigated variables was significant. This pilot study has demonstrated the feasibility of investigating the association between neonatal sepsis mortality and the causative Enterobacterales isolates virulome. This relationship needs further exploration in larger studies, ideally including host immunopathological response, in order to develop a tailor-made therapeutic strategy.

Highlights

  • Mortality in neonates with Gram-negative bloodstream infections (GN-BSIs) has remained unacceptably high

  • We aimed to investigate potential associations between patient characteristics, pathogen characteristics and antibiotic treatment regimen on the clinical outcome of neonates/infants affected by culture-proven GN-BSIs

  • Early age at onset, GA at the onset, culture positive for E. coli and number of classes of virulence genes carried by each isolate were significantly associated with mortality whereas discordant therapy was not related to mortality

Read more

Summary

Introduction

Mortality in neonates with Gram-negative bloodstream infections (GN-BSIs) has remained unacceptably high. Despite the improvement in neonatal care, the fatality rate in babies with GN-BSIs remains around 15–20%, during the emergence of antimicrobial resistance (AMR) [1,2,3,4,5,6]. Very few data are available on the impact of different treatment regimens on clinical outcome in neonates with GN-BSIs. Previous studies conducted in both adults and children showed conflicting results on the impact of resistance profiles, appropriateness of empirical treatment and clinical characteristics on patients’ mortality [7,8,9,10,11,12,13,14,15]. There has been a growing body of evidence about the role of virulence factors (VFs) in the pathogenesis of invasive infections

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call